Searched for
GROWTH IN PHARMACEUTICALS
From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plans- ETMarkets Smart Talk: Smallcap investors should consider a five-year SIP horizon amid volatility: Sorbh Gupta
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%
- Himadri Speciality Chemicals plans Rs 1,613-cr capacity expansion across key businessesHimadri Speciality Chemicals Ltd is implementing a growth strategy focused on capacity expansion and investment. The company plans to inves...22 Oct, 2026, 03.45 PM IST
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...22 Oct, 2026, 06.33 AM IST
- ETMarkets Smart Talk| India’s next wealth creators may be hidden in specialised manufacturing and energy infrastructure: Paresh BhagatParesh Bhagat, Chairman of Mangal Keshav Financial Services, discusses where India’s next wealth creators could emerge from, why several mi...21 Oct, 2026, 09.10 AM IST
- India-New Zealand FTA comes into effect todayThe FTA will provide Indian exporters with 100% duty-free access to the New Zealand market, opening opportunities for MSMEs, women entrepre...20 Oct, 2026, 12.02 AM IST
- Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...19 Oct, 2026, 06.08 AM IST
- Charting the global economy: Inflationary pressures mount in USA broad upswing in consumer prices last month helps reinforce expectations for additional Federal Reserve interest-rate increases in the mo...18 Oct, 2026, 09.12 AM IST
- ETMarkets Smart Talk | Manufacturing, healthcare and financialisation could create India’s next wealth creators: Sanjay DoshiAbakkus Mutual Fund’s Sanjay Doshi sees opportunities across market capitalisations, despite elevated mid- and smallcap valuations. He urge...17 Oct, 2026, 11.29 AM IST
- 5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...17 Oct, 2026, 06.12 AM IST
- Donald Trump raised stakes in drug companies gaining from medicare exemptions, say DemocratsInvestments in pharmaceutical companies on behalf of Donald Trump saw a significant increase after returning to the White House. His portfo...17 Oct, 2026, 12.57 AM IST
- The $50-billion question: Who gets what as India and Canada aim to strike a trade deal?India and Canada are currently negotiating a free trade agreement designed to enhance bilateral trade significantly. Nearly 300 Canadian bu...16 Oct, 2026, 03.30 PM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...16 Oct, 2026, 10.12 AM IST
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...15 Oct, 2026, 04.19 PM IST
- Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...15 Oct, 2026, 07.21 AM IST
- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...14 Oct, 2026, 08.28 PM IST
- Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...13 Oct, 2026, 10.10 AM IST
- NuSynth Technologies raises Rs 36.5 crore in round led by Avaana Capital, Shastra VCThe company is developing a platform to find simpler, cheaper and more efficient ways to make chemicals, said cofounders Poorvank Purohit a...13 Oct, 2026, 10.07 AM IST
- From pharma to Scotch whisky, UK has "huge" export potential in India: Commerce Minister Piyush GoyalSpeaking at the India-UK JETCO Business Plenary on Monday, Goyal highlighted the complementary nature of the two economies and stressed the...12 Oct, 2026, 07.26 PM IST
Load More
